Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 155 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Desc)]
Φίλτρα: Συντάκτης is Fountzilas, George  [Clear All Filters]
2009
Pectasides, D., Fountzilas G., Papaxoinis G., Pectasides E., Xiros N., Sykiotis C., et al. (2009).  Carboplatin and paclitaxel in metastatic or recurrent cervical cancer.. Int J Gynecol Cancer. 19(4), 777-81.
Briasoulis, E., Pappas P., Puozzo C., Tolis C., Fountzilas G., Dafni U., et al. (2009).  Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer.. Clin Cancer Res. 15(20), 6454-61.
Pentheroudakis, G., Kalogeras K. T., Wirtz R. M., Grimani I., Zografos G., Gogas H., et al. (2009).  Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.. Breast Cancer Res Treat. 116(1), 131-43.
Iliadis, G., Selviaridis P., Kalogera-Fountzila A., Fragkoulidi A., Baltas D., Tselis N., et al. (2009).  The importance of tumor volume in the prognosis of patients with glioblastoma: comparison of computerized volumetry and geometric models.. Strahlenther Onkol. 185(11), 743-50.
Fountzilas, G., Bamias A., Kalogera-Fountzila A., Karayannopoulou G., Bobos M., Athanassiou E., et al. (2009).  Induction chemotherapy with docetaxel and cisplatin followed by concomitant chemoradiotherapy in patients with inoperable non-nasopharyngeal carcinoma of the head and neck.. Anticancer Res. 29(2), 529-38.
Fountzilas, G., Kalogera-Fountzila A., Lambaki S., Wirtz R. M., Nikolaou A., Karayannopoulou G., et al. (2009).  MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.. J Oncol. 2009, 305908.
Skarlos, D. V., Timotheadou E., Galani E., Samantas E., Grimani I., Lianos E., et al. (2009).  Pegfilgrastim administered on the same day with dose-dense adjuvant chemotherapy for breast cancer is associated with a higher incidence of febrile neutropenia as compared to conventional growth factor support: matched case-control study of the Hellenic C. Oncology. 77(2), 107-12.
Razis, E., Selviaridis P., Labropoulos S., Norris J. L., Zhu M-J., Song D. D., et al. (2009).  Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.. Clin Cancer Res. 15(19), 6258-66.
Escudier, B., Roigas J., Gillessen S., Harmenberg U., Srinivas S., Mulder S. F., et al. (2009).  Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma.. J Clin Oncol. 27(25), 4068-75.
Pectasides, D., Dafni U., Bafaloukos D., Skarlos D., Polyzos A., Tsoutsos D., et al. (2009).  Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa-2b in patients with resected high-risk melanoma.. J Clin Oncol. 27(6), 939-44.
Kotoula, V., Charalambous E., Biesmans B., Malousi A., Vrettou E., Fountzilas G., et al. (2009).  Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics.. PLoS One. 4(11), e7746.
Kostopoulos, I., Karavasilis V., Karina M., Bobos M., Xiros N., Pentheroudakis G., et al. (2009).  Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy.. BMC Cancer. 9, 339.
Pentheroudakis, G., Angouridakis N., Wirtz R., Nikolaou A., Kalogeras K. T., Pavlidis N., et al. (2009).  Transcriptional activity of human epidermal growth factor receptor family and angiogenesis effectors in locoregionally recurrent head and neck squamous cell carcinoma and correlation with patient outcome.. J Oncol. 2009, 854127.
Christodoulou, C., Kostopoulos I., Kalofonos H. P., Lianos E., Bobos M., Briasoulis E., et al. (2009).  Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation.. Oncology. 76(4), 275-85.
Papadimitriou, C. A., Kalofonos H., Zagouri F., Papakostas P., Bozas G., Makatsoris T., et al. (2009).  Weekly docetaxel with or without gemcitabine as second-line chemotherapy in paclitaxel-pretreated patients with metastatic breast cancer: a randomized phase II study conducted by the Hellenic Co-Operative Oncology Group.. Oncology. 77(3-4), 212-6.
Maniadakis, N., Fragoulakis V., Pectasides D., & Fountzilas G. (2009).  XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis.. Curr Med Res Opin. 25(3), 797-805.
2010
Koutras, A. K., Fountzilas G., Makatsoris T., Peroukides S., & Kalofonos H. P. (2010).  Bevacizumab in the treatment of breast cancer.. Cancer Treat Rev. 36(1), 75-82.
De Roock, W., Claes B., Bernasconi D., De Schutter J., Biesmans B., Fountzilas G., et al. (2010).  Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.. Lancet Oncol. 11(8), 753-62.
Gogas, H., Dafni U., Koon H., Spyropoulou-Vlachou M., Metaxas Y., Buchbinder E., et al. (2010).  Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial.. J Transl Med. 8, 108.
Kalofonos, H. P., Papakostas P., Makatsoris T., Papamichael D., Vourli G., Xanthakis I., et al. (2010).  Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer.. Anticancer Res. 30(10), 4325-33.
Antoniou, A. C., Wang X., Fredericksen Z. S., McGuffog L., Tarrell R., Sinilnikova O. M., et al. (2010).  A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.. Nat Genet. 42(10), 885-92.
Fostira, F., Thodi G., Sandaltzopoulos R., Fountzilas G., & Yannoukakos D. (2010).  Mutational spectrum of APC and genotype-phenotype correlations in Greek FAP patients.. BMC Cancer. 10, 389.
Pectasides, E., Egloff A-M., Sasaki C., Kountourakis P., Burtness B., Fountzilas G., et al. (2010).  Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosis.. Clin Cancer Res. 16(8), 2427-34.
Gogas, H., Pectasides D., Kostopoulos I., Lianos E., Skarlos D., Papaxoinis G., et al. (2010).  Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology Group.. Clin Breast Cancer. 10(3), 230-7.
Briasoulis, E., Golfinopoulos V., Karina M., Papakostas P., Pavlidis N., & Fountzilas G. (2010).  Phase I trial of weekly irinotecan and paclitaxel combined with carboplatin in patients with advanced cancer: a Hellenic Cooperative Oncology Group Study.. Anticancer Drugs. 21(8), 785-9.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές